+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
ID07390071

Telerehabilitation Program for Adults with Blood Cancers Undergoing CAR-T Cell Therapy Using Personalized Exercise, Nutrition, and Support Delivered at Home

Led by University of Utah · Updated on 2026-02-05

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are exploring a new telerehabilitation program for patients receiving CAR-T cell immunotherapy for blood cancers like lymphoma and myeloma. This approach aims to improve quality of life, physical function, and symptoms by offering personalized exercise, nutrition, behavioral counseling, social support, and education. The study focuses on the safety and feasibility of this model using an online platform that monitors patients health and progress in real-time with the help of artificial intelligence. Participants will start with a four-week personalized prehabilitation program before starting CAR-T therapy. During treatment, they will use an interactive app for cancer self-care education and early mobilization while undergoing chemotherapy, CAR-T infusion, and hospital monitoring. After discharge, they will follow a 12-week home-based multimodal telerehabilitation plan that includes exercises, nutrition guidance, and social support through group telecounseling, all monitored via web-based tools and wearable devices like pulse oximeters and fitness trackers. Throughout the study, patients will be assessed for usability and adherence to the program, along with measures of physical fitness, quality of life, symptoms, and satisfaction with care. Assessments include walking tests, physical performance batteries, questionnaires on fatigue and exercise motivation, and cancer-related quality of life surveys. The study lasts up to 12 weeks after CAR-T treatment completion, with ongoing monitoring of exercise exertion and patient-reported outcomes to evaluate the programs impact and feasibility.

CONDITIONS

Brief Title

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

Research Team

A

Aileen Gabriel

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here